Eli Lilly & Co
LLY· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q4 2019 | Q4 2018 | Q4 2017 | Q4 2016 |
|---|---|---|---|---|
| Revenue | $6.11B | $5.64B | $6.16B | $5.76B |
| Net Income | $1.50B | $1.13B | -$1.66B | $771.80M |
| EPS Diluted | $1.64 |
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
| $1.10 |
| -$1.58 |
| $0.73 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.